EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of [68Ga]Ga-FAPI PET/CT with CECT in the detection of peritoneal metastases from ovarian cancers and impact on clinical treatment decisions

Yunuan Liu, Fenglian Jing, Xiaoshan Chen, Tingting Wang, Xiaolin Chen, Danying Zhao, Yuhan Sun, Meng Dai, Na Wang, Ting Zhang, Zhaoqi Zhang, Jiangyang Pan und 1 weitere

Abdominal Radiology · 04.06.2026 · 51 (12) · 6496-6506

DOI: 10.1007/s00261-026-05583-1 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Abdominal Radiology, online erschienen am 04.06.2026. Verfasst von Yunuan Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Positron Emission Tomography Computed Tomography, Peritoneal Neoplasms, Tomography, X-Ray Computed. Die Arbeit nennt 34 Literaturangaben. Gefördert von: The Health Commission Foundation of Hebei Province, The Hebei Provincial Medical Applicable Technology Tracking Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To explore the diagnostic value of [68Ga]Ga-FAPI PET/CT for peritoneal metastases in ovarian cancer and its impact on clinical decisions, in comparison to contrast-enhanced computed tomography (CECT). METHODS: We retrospectively enrolled consecutive patients with ovarian cancer who underwent both [68Ga]Ga-FAPI PET/CT and CECT within two weeks between April 2022 and June 2025. Histopathology or imaging follow-up served as the reference. The peritoneal cancer index (PCI)-region and PCI score were evaluated between [68Ga]Ga-FAPI PET/CT and CECT. The diagnostic efficacy was evaluated by comparing analyses based on patients and lesions. The impact of [68Ga]Ga-FAPI PET/CT on treatment was examined via simulated multidisciplinary consultation. In addition, the differences in diagnostic performance of [68Ga]Ga-FAPI PET/CT, CECT, and carbohydrate antigen 125 (CA125) for suspected recurrent ovarian cancer were also compared. RESULTS: Of the 36 patients, 5 patients were newly diagnosed and 31 patients had received prior treatment. The PCI-regions and PCI score of [68Ga]Ga-FAPI PET/CT were higher than CECT [median PCI-regions: 3 (2, 8) vs. 2 (1, 5), P < 0.001 and median PCI score: 6 (4, 16.8) vs. 5 (2, 11.5), P = 0.002]. [68Ga]Ga-FAPI PET/CT demonstrated higher sensitivity for detecting peritoneal metastases based on the lesion-based analysis [95.56% (43/45) vs. 60% (27/45), P = 0.003]. In the patient-based analysis, the sensitivity of [68Ga]Ga-FAPI PET/CT for lymph node metastases was significantly higher [94.44% (17/18) vs. 61.11% (11/18), P = 0.031]. Compared to CECT, [68Ga]Ga-FAPI PET/CT results prompted treatment modifications in 22.22% (8/36) of patients, with 19.44% (7/36) patients due to new findings of peritoneal metastases. The sensitivity of [68Ga]Ga-FAPI PET/CT was significantly different from that of CA125 in diagnosing recurrent ovarian cancer [96.43% (27/28) vs. 67.86% (19/28), P = 0.008]. CONCLUSION: [68Ga]Ga-FAPI PET/CT was superior to CECT for the detection of peritoneal metastases, which aids in guiding clinical decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsPositron Emission Tomography Computed TomographyPeritoneal NeoplasmsTomography, X-Ray ComputedHumansFemaleRetrospective StudiesMiddle AgedRadiopharmaceuticalsAgedGallium RadioisotopesContrast MediaAdultSensitivity and SpecificityQuinolines

Stichwörter der Autor:innen

Ovarian cancerPeritoneal metastasesTreatment decision[68Ga]Ga-FAPI

Substanzen

Radiopharmaceuticals68Ga-FAPIGallium RadioisotopesContrast MediaQuinolines

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. zhangsir1979@hebmu.edu.cn.
  • Department of Radiology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. 48801893@hebmu.edu.cn.
  • Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. xinmingzhao@hebmu.edu.cn.
  • Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Shijiazhuang, China. xinmingzhao@hebmu.edu.cn.

Förderung

  • The Health Commission Foundation of Hebei Province
  • The Hebei Provincial Medical Applicable Technology Tracking Project

Zitieren

APA

Liu, Y., Jing, F., Chen, X., Wang, T., Chen, X., Zhao, D., Sun, Y., Dai, M., Wang, N., Zhang, T., Zhang, Z., Pan, J., & Zhao, X. (2026). Comparison of [68Ga]Ga-FAPI PET/CT with CECT in the detection of peritoneal metastases from ovarian cancers and impact on clinical treatment decisions. Abdominal Radiology, 51(12), 6496-6506. https://doi.org/10.1007/s00261-026-05583-1

Vancouver

Liu Y, Jing F, Chen X, Wang T, Chen X, Zhao D, et al. Comparison of [68Ga]Ga-FAPI PET/CT with CECT in the detection of peritoneal metastases from ovarian cancers and impact on clinical treatment decisions. Abdominal Radiology. 2026;51(12):6496-6506. doi:10.1007/s00261-026-05583-1

BibTeX
@article{Liu2026,
  author = {Liu, Yunuan and Jing, Fenglian and Chen, Xiaoshan and Wang, Tingting and Chen, Xiaolin and Zhao, Danying and Sun, Yuhan and Dai, Meng and Wang, Na and Zhang, Ting and Zhang, Zhaoqi and Pan, Jiangyang and Zhao, Xinming},
  title = {Comparison of [68Ga]Ga-FAPI PET/CT with CECT in the detection of peritoneal metastases from ovarian cancers and impact on clinical treatment decisions},
  journal = {Abdominal Radiology},
  year = {2026},
  volume = {51},
  number = {12},
  pages = {6496--6506},
  doi = {10.1007/s00261-026-05583-1}
}
Kostenlos starten →